Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a diabetes pill help heart failure patients get rid of excess fluid?

NCT ID NCT05305495

First seen Apr 04, 2026 · Last updated Jun 18, 2026 · Updated 12 times

Summary

This study tested whether adding empagliflozin (a diabetes drug) to standard diuretics helps hospitalized heart failure patients with moderate to advanced kidney disease urinate more fluid. 25 participants were given the combination, and researchers measured urine output. The goal was to see if this approach could overcome diuretic resistance and improve fluid removal.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Research Institute of the McGill University Health Center

    Montreal, Quebec, Canada

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.